Valera Pharmaceuticals Inc Forecast and Stock Analysis
Technical VLRX stock analysis for March 25, 2019.
Valera Pharmaceuticals Inc fell by -4.59% in the last day from $0.35 to $0.33 and has now fallen 5 days in a row. The price has fallen in 7 of the last 10 days and is down by -17.45% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -0.75 million shares and in total 1.23 million shares bought and sold for approximately $406 841.00.
Close price at the end of the last trading day (Monday, 25th Mar 2019) of the VLRX stock was $0.33. This is 4.59% less than the trading day before Friday, 22nd Mar 2019.
During day the stock fluctuated 12.90% from a day low at $0.31 to a day high of $0.35.
30 day high of the VLRX stock price was $0.57 and low was $0.31.
90 day high was $0.57 and low was $0.30.
52 week high for the Valera Pharmaceuticals Inc - $4.58 and low - $0.30.
Valera Pharmaceuticals Inc has broken the very wide and weak rising short-term trend down. This signalize a slower rising rate, but may also be an early warning about a possible trend shift. Due to trend being broken there will now be resistance at the bottom line of the trend at $0.40. A reaction back to this level may hold a second chance to get out before further falls.
There are few to none technical positive signals at the moment. Valera Pharmaceuticals Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.37 and $0.41. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday March 05, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSI14 is 4 and the stock is extremely oversold on RSI14, but some stocks may continue to fall despite the high chance of a correction up. The low RSI lowers the general risk and the stock should be considered if other technical requirements like liquidity and risk-reward are meet.
Support & Resistance
Valera Pharmaceuticals Inc finds support from accumulated volume at $0.33.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.04 between high and low, or 12.90%. For the last week the stock has had a daily average volatility of 6.77%.
Valera Pharmaceuticals Inc is overbought on RSI14 (4). Some stocks may go long and hard while being overbought on RSI, but overbought increases the general risk as higher volatility could be expected, and at some level the stock will have a reaction back to gain new strength.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
The Valera Pharmaceuticals Inc stock holds several negative signals and despite the positive trend we believe Valera Pharmaceuticals Inc will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.